Alpha 2.0
Login Register
» Articles » PMID: 3440247

Amelioration of Adriamycin Toxicity Through Modification of Drug-DNA Binding Properties

Overview
Journal Cancer Treat Rev
Publisher Elsevier
Specialty Oncology
Date 1987 Dec 1
PMID 3440247
Citations 6
Authors
M Israel
R Seshadri
Y Koseki
T W Sweatman
J M Idriss
Affiliations
Soon will be listed here.
Citing Articles

Photo-controlled delivery of a potent analogue of doxorubicin.

Dupart P, Mitra K, Lyons C, Hartman M Chem Commun (Camb). 2019; 55(39):5607-5610.

PMID: 31021353 PMC: 6643956. DOI: 10.1039/c9cc02050k.

Pharmacology of N,N-di(n-butyl)adriamycin-14-valerate in the rat.

Han G, Israel M, Seshadri R, Dalton J, Sweatman T Cancer Chemother Pharmacol. 1996; 37(5):472-8.

PMID: 8599871 DOI: 10.1007/s002800050414.

Growth inhibition of human Tenon's capsule fibroblasts and rabbit dermal fibroblasts with non-carcinogenic N-alkylated anthracyclines.

Steinhorst U, Chen E, Freedman S, MACHEMER R, Hatchell D Graefes Arch Clin Exp Ophthalmol. 1994; 232(6):347-54.

PMID: 8082842 DOI: 10.1007/BF00175986.

N-benzyladriamycin-14-valerate versus progressively doxorubicin-resistant murine tumours: cellular pharmacology and characterisation of cross-resistance in vitro and in vivo.

Ganapathi R, Grabowski D, Sweatman T, Seshadri R, Israel M Br J Cancer. 1989; 60(6):819-26.

PMID: 2605093 PMC: 2247277. DOI: 10.1038/bjc.1989.373.

Comparative uptake and retention of adriamycin and N-benzyladriamycin-14-valerate in human CEM leukemic lymphocyte cell cultures.

Israel M, Sweatman T, Seshadri R, Koseki Y Cancer Chemother Pharmacol. 1989; 25(3):177-83.

PMID: 2598408 DOI: 10.1007/BF00689579.